Related Experiment Videos
SLiMs go viral! One more weapon against interferon.
Lisa Miorin1, Maria Teresa Sanchez-Aparicio1
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cell Host & Microbe
|March 10, 2022
Summary
Viruses like poxviruses and paramyxoviruses use common strategies to suppress the innate immune response. This viral mechanism limits antiviral gene expression, promoting infection and disease.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The innate immune system is the first line of defense against viral infections.
- Viruses have evolved diverse mechanisms to evade or antagonize host immune responses.
- Understanding viral immune evasion strategies is crucial for developing antiviral therapies.
Purpose of the Study:
- To investigate common mechanisms employed by poxviruses and paramyxoviruses to counteract the innate immune response.
- To identify specific viral strategies targeting universal activators of innate immunity.
- To elucidate how these viral mechanisms contribute to virulence.
Main Methods:
- Comparative analysis of poxvirus and paramyxovirus genomes and proteomes.
- In vitro assays to assess the impact of viral proteins on innate immune signaling pathways.
- Gene expression analysis to quantify antiviral gene induction in infected cells.
Main Results:
- A conserved mechanism was identified where both poxviruses and paramyxoviruses target key activators of the innate immune response.
- Viral proteins were shown to inhibit the expression of essential antiviral genes.
- This suppression of host defenses was directly linked to increased viral virulence.
Conclusions:
- Poxviruses and paramyxoviruses share a common strategy to disarm the innate immune system by targeting universal immune activators.
- This viral immune evasion tactic is critical for efficient viral replication and pathogenesis.
- The findings provide insights into host-pathogen interactions and potential therapeutic targets.